Hyperfine Inc (HYPR)

$1.56 -0.04 (-2.50%)
Market Cap 154.86M
Revenue (ttm) 13.56M
Net Income (ttm) -35.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -262.32%
Debt to Equity Ratio 0.38
Volume 710,900
Avg Vol 616,046
Day's Range N/A - N/A
Shares Out 99.27M
Stochastic %K 54%
Beta 1.42
Analysts Strong Sell
Price Target $2.17

Company Profile

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departm...

Industry: Medical Devices
Sector: Healthcare
Phone: 866 796 6767
Address:
351 New Whitfield Street, Guilford, United States
beckinvestllc
beckinvestllc May. 28 at 8:58 PM
$FCEL, $HYPR, $NKTR, $OCGN, $QSI 5 tickers poised to pop. Which one will be the first? Any one have thoughts they would like to share about any of them?
1 · Reply
SuperGreenToday
SuperGreenToday May. 26 at 10:46 PM
$HYPR Share Price: $1.66 Contract Selected: Jan 15, 2027 $2.5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.68 – $0.83 Potential Upside: 50% ROI Time to Expiration: 233 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 26 at 8:34 PM
$HYPR pretty good day. I’m still hoping that it’s a buyout candidate.
0 · Reply
Dynel
Dynel May. 26 at 6:48 PM
$HYPR
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 26 at 6:28 PM
$HYPR $BFLY Congrats to $HYPR! Added to the Russell 2000!
1 · Reply
DARKP00L
DARKP00L May. 26 at 1:02 PM
$HYPR 08:45 on May. 26 2026 Hyperfine Expected To Join Russell 3000 Index And Small-Cap Russell 2000 Index At End Of Russell Reconstitution In June #tradeideas
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 26 at 12:20 PM
$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-join-russell-2000r-and-russell-3000r-indexes
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 23 at 12:21 AM
$BFLY $HYPR HYPR added to the Russell 2000 !!!
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 22 at 11:24 PM
$HYPR First to cover, you must be…
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 22 at 11:21 PM
$HYPR congrats to HYPR for officially making the FTSE RUSSELL 3000 PRELIMINARY ADDITIONS list.
0 · Reply
Latest News on HYPR
Hyperfine to join Russell 2000, Russell 3000 Indexes

2026-05-26T15:26:37.000Z - 4 days ago

Hyperfine to join Russell 2000, Russell 3000 Indexes

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

May 26, 2026, 8:15 AM EDT - 4 days ago

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

Hyperfine presents PRIME study results on portable MRI at SAEM meeting

2026-05-22T12:19:18.000Z - 8 days ago

Hyperfine presents PRIME study results on portable MRI at SAEM meeting

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

May 22, 2026, 8:15 AM EDT - 8 days ago

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine Transcript: AGM 2026

May 21, 2026, 10:00 AM EDT - 9 days ago

Hyperfine Transcript: AGM 2026

Hyperfine management to meet virtually with Lake Street

2026-05-15T17:16:21.000Z - 15 days ago

Hyperfine management to meet virtually with Lake Street

Hyperfine management to meet virtually with Oppenheimer

2026-05-15T17:09:38.000Z - 15 days ago

Hyperfine management to meet virtually with Oppenheimer

Hyperfine price target raised to $2 from $1.60 at B. Riley

2026-05-13T14:09:00.000Z - 17 days ago

Hyperfine price target raised to $2 from $1.60 at B. Riley

Hyperfine Q1 Earnings Call Highlights

May 12, 2026, 8:25 PM EDT - 18 days ago

Hyperfine Q1 Earnings Call Highlights

Hyperfine reports Q1 EPS (9c), consensus (9c)

2026-05-12T22:02:48.000Z - 18 days ago

Hyperfine reports Q1 EPS (9c), consensus (9c)

Hyperfine still sees FY26 revenue $20M-$22M, consensus $20.04M

2026-05-12T22:00:18.000Z - 18 days ago

Hyperfine still sees FY26 revenue $20M-$22M, consensus $20.04M

Hyperfine files to sell 1.08M shares of Class A common stock for holders

2026-05-12T20:51:05.000Z - 18 days ago

Hyperfine files to sell 1.08M shares of Class A common stock for holders

Hyperfine Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 18 days ago

Hyperfine Earnings Call Transcript: Q1 2026

Hyperfine Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 18 days ago

Hyperfine Earnings release: Q1 2026

Hyperfine Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 18 days ago

Hyperfine Quarterly report: Q1 2026

Hyperfine Slides: Q1 2026

May 12, 2026, 4:30 PM EDT - 18 days ago

Hyperfine Slides: Q1 2026

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

May 12, 2026, 4:05 PM EDT - 18 days ago

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

Hyperfine Registration statement: Registration filing

May 12, 2026, 8:00 AM EDT - 18 days ago

Hyperfine Registration statement: Registration filing

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

May 6, 2026, 4:05 PM EDT - 24 days ago

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop

2026-04-29T14:46:17.000Z - 4 weeks ago

Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

Apr 29, 2026, 8:15 AM EDT - 4 weeks ago

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

Hyperfine initiated with a Buy at BTIG

2026-04-29T11:33:03.000Z - 4 weeks ago

Hyperfine initiated with a Buy at BTIG

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

Apr 28, 2026, 4:05 PM EDT - 4 weeks ago

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

Hyperfine receives CE Marking, UK Conformity Assessment approval

2026-04-09T14:24:32.000Z - 7 weeks ago

Hyperfine receives CE Marking, UK Conformity Assessment approval

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

Apr 9, 2026, 8:15 AM EDT - 7 weeks ago

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

Hyperfine Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 7 weeks ago

Hyperfine Proxy statement: Proxy filing

Hyperfine Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 7 weeks ago

Hyperfine Proxy statement: Proxy filing

Horizon Technology provides $40M loan facility to Hyperfine

2026-03-23T12:10:42.000Z - 2 months ago

Horizon Technology provides $40M loan facility to Hyperfine

HRZN

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

Mar 23, 2026, 8:00 AM EDT - 2 months ago

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

HRZN

Hyperfine price target raised to $1.60 from $1.30 at B. Riley

2026-03-19T12:56:16.000Z - 2 months ago

Hyperfine price target raised to $1.60 from $1.30 at B. Riley

Hyperfine price target raised to $2.50 from $2 at Lake Street

2026-03-19T12:45:51.000Z - 2 months ago

Hyperfine price target raised to $2.50 from $2 at Lake Street

Hyperfine Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

Hyperfine Earnings Call Transcript: Q4 2025

Hyperfine Annual report: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

Hyperfine Annual report: Q4 2025

Hyperfine Earnings release: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

Hyperfine Earnings release: Q4 2025

Hyperfine Slides: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

Hyperfine Slides: Q4 2025

Hyperfine reports Q4 EPS (6c) vs (14c) last year

2026-03-18T20:12:26.000Z - 2 months ago

Hyperfine reports Q4 EPS (6c) vs (14c) last year

Hyperfine sees FY26 revenue $20M-$22M, one estimate $18M

2026-03-18T20:12:21.000Z - 2 months ago

Hyperfine sees FY26 revenue $20M-$22M, one estimate $18M

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 18, 2026, 4:05 PM EDT - 2 months ago

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Mar 5, 2026, 4:05 PM EST - 3 months ago

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities

Jan 27, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities

Hyperfine announces results from NEURO PMR study

2026-01-20T13:20:42.000Z - 4 months ago

Hyperfine announces results from NEURO PMR study

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Jan 20, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Hyperfine enrolls first patient in Contrast PMR study

2026-01-15T13:21:26.000Z - 4 months ago

Hyperfine enrolls first patient in Contrast PMR study

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Jan 15, 2026, 8:15 AM EST - 4 months ago

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M

2026-01-12T13:41:42.000Z - 4 months ago

Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Jan 12, 2026, 8:15 AM EST - 4 months ago

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Hyperfine Slides: Investor presentation

Jan 12, 2026, 7:00 AM EST - 4 months ago

Hyperfine Slides: Investor presentation

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Jan 6, 2026, 8:15 AM EST - 5 months ago

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Hyperfine announces regulatory approval of Swoop System in India

2025-12-17T13:36:39.000Z - 5 months ago

Hyperfine announces regulatory approval of Swoop System in India

Hyperfine Announces Regulatory Approval of the Swoop® System in India

Dec 17, 2025, 8:15 AM EST - 5 months ago

Hyperfine Announces Regulatory Approval of the Swoop® System in India

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Dec 15, 2025, 8:15 AM EST - 5 months ago

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Hyperfine Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 8:10 AM EST - 6 months ago

Hyperfine Transcript: Piper Sandler 37th Annual Healthcare Conference

Hyperfine Slides: Investor Presentation

Dec 4, 2025, 7:00 AM EST - 6 months ago

Hyperfine Slides: Investor Presentation

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 4:05 PM EST - 6 months ago

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Nov 19, 2025, 8:15 AM EST - 6 months ago

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Hyperfine Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Hyperfine Earnings Call Transcript: Q3 2025

Hyperfine Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Hyperfine Quarterly report: Q3 2025

Hyperfine Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Hyperfine Earnings release: Q3 2025

Hyperfine Slides: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Hyperfine Slides: Q3 2025

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:05 PM EST - 7 months ago

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Oct 30, 2025, 4:05 PM EDT - 7 months ago

Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

Oct 21, 2025, 8:15 AM EDT - 7 months ago

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

Hyperfine Announces Pricing of $17.5 Million Public Offering

Oct 16, 2025, 8:00 AM EDT - 8 months ago

Hyperfine Announces Pricing of $17.5 Million Public Offering

Hyperfine Announces Proposed Public Offering

Oct 15, 2025, 4:06 PM EDT - 8 months ago

Hyperfine Announces Proposed Public Offering

Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Oct 15, 2025, 4:05 PM EDT - 8 months ago

Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

Oct 13, 2025, 8:15 AM EDT - 8 months ago

Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

Oct 6, 2025, 8:15 AM EDT - 8 months ago

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

Hyperfine Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 12:00 PM EDT - 9 months ago

Hyperfine Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Sep 2, 2025, 8:15 AM EDT - 9 months ago

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Aug 25, 2025, 8:15 AM EDT - 9 months ago

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Hyperfine Earnings Call Transcript: Q2 2025

Hyperfine Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Hyperfine Quarterly report: Q2 2025

Hyperfine Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Hyperfine Earnings release: Q2 2025

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:05 PM EDT - 10 months ago

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Hyperfine Slides: Investor Presentation

Aug 13, 2025, 4:00 PM EDT - 10 months ago

Hyperfine Slides: Investor Presentation

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

Aug 4, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

Jul 31, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference

Jul 28, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

Jul 24, 2025, 8:15 AM EDT - 11 months ago

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Jul 23, 2025, 8:15 AM EDT - 11 months ago

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

Jul 17, 2025, 8:15 AM EDT - 11 months ago

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

Jun 11, 2025, 9:00 AM EDT - 1 year ago

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

Hyperfine Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 4:20 PM EDT - 1 year ago

Hyperfine Transcript: Jefferies Global Healthcare Conference 2025

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

Jun 2, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

May 28, 2025, 9:00 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

May 15, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Hyperfine Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q1 2025

Hyperfine Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Quarterly report: Q1 2025

Hyperfine Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings release: Q1 2025

Hyperfine Slides: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Slides: Q1 2025

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Apr 29, 2025, 4:28 PM EDT - 1 year ago

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Apr 15, 2025, 4:00 PM EDT - 1 year ago

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Hyperfine Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Hyperfine Proxy statement: Proxy Filing

Hyperfine Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Hyperfine Proxy statement: Proxy Filing

Hyperfine Earnings Call Transcript: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q4 2024

Hyperfine Annual report: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Annual report: Q4 2024

Hyperfine Earnings release: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings release: Q4 2024

Hyperfine Slides: Q4 2024

Mar 17, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Slides: Q4 2024

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 4, 2025, 4:05 PM EST - 1 year ago

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine Announces $6.0 Million Registered Direct Offering

Feb 11, 2025, 8:02 AM EST - 1 year ago

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Feb 6, 2025, 4:05 PM EST - 1 year ago

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Dec 17, 2024, 9:00 AM EST - 1 year ago

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

beckinvestllc
beckinvestllc May. 28 at 8:58 PM
$FCEL, $HYPR, $NKTR, $OCGN, $QSI 5 tickers poised to pop. Which one will be the first? Any one have thoughts they would like to share about any of them?
1 · Reply
SuperGreenToday
SuperGreenToday May. 26 at 10:46 PM
$HYPR Share Price: $1.66 Contract Selected: Jan 15, 2027 $2.5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.68 – $0.83 Potential Upside: 50% ROI Time to Expiration: 233 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 26 at 8:34 PM
$HYPR pretty good day. I’m still hoping that it’s a buyout candidate.
0 · Reply
Dynel
Dynel May. 26 at 6:48 PM
$HYPR
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 26 at 6:28 PM
$HYPR $BFLY Congrats to $HYPR! Added to the Russell 2000!
1 · Reply
DARKP00L
DARKP00L May. 26 at 1:02 PM
$HYPR 08:45 on May. 26 2026 Hyperfine Expected To Join Russell 3000 Index And Small-Cap Russell 2000 Index At End Of Russell Reconstitution In June #tradeideas
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 26 at 12:20 PM
$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-join-russell-2000r-and-russell-3000r-indexes
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 23 at 12:21 AM
$BFLY $HYPR HYPR added to the Russell 2000 !!!
1 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 22 at 11:24 PM
$HYPR First to cover, you must be…
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 22 at 11:21 PM
$HYPR congrats to HYPR for officially making the FTSE RUSSELL 3000 PRELIMINARY ADDITIONS list.
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 22 at 10:56 PM
$HYPR It’s official !!! Added to the Russell 2000!
1 · Reply
Cold_in_the_North
Cold_in_the_North May. 22 at 9:05 PM
$HYPR
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 22 at 8:49 PM
$HYPR
0 · Reply
focafoca99
focafoca99 May. 22 at 12:39 PM
$HYPR demonstrated a major time-to-imaging reduction with its portable MRI in the PRIME study.
0 · Reply
Cold_in_the_North
Cold_in_the_North May. 22 at 12:31 PM
$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-announces-presentation-results-prime-study-showing/
0 · Reply
DARKP00L
DARKP00L May. 22 at 12:18 PM
$HYPR 08:17 on May. 22 2026 Hyperfine Presents PRIME Study Results At SAEM 2026 Annual Meeting #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher May. 22 at 12:15 PM
$HYPR Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 20 at 7:26 PM
$BFLY $HYPR
0 · Reply
Number_4
Number_4 May. 19 at 2:22 PM
$HYPR Back to $1.25 as predicted.
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 15 at 10:34 PM
$HYPR $16B TAM and they only had $3.9M in sales last quarter. The sky is the limit!!! Just a matter of time…
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 15 at 10:20 PM
$HYPR
0 · Reply
TheWideOpenRoad
TheWideOpenRoad May. 15 at 10:19 PM
$HYPR
0 · Reply